Product Information
FLUOXETINE HCL 20 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0838 per EA under NDC 43598056601. Its NADAC has been published 428 times since Jul 25, 2018.
FDA first approved this application on Jan 30, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598056601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076006FDA Approved
1/30/2002
TE Code
AB
On Market Since
5/8/2018
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 20 MG TABLET has been published 428 times since Jul 25, 2018, and over the history we have for it it has declined 93.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0838 per EA |
|---|---|
| All-time high | $1.3043 (Sep 12, 2018) |
| All-time low | $0.0653 (Nov 20, 2024) |
| 52-week high | $0.1086 |
| 52-week low | $0.0838 |
| Median price | $0.2122 |
| Average price | $0.3244 |
| Largest weekly change | +51.8% (Nov 22, 2023) |
| Weeks tracked | 428 |
| Tracking since | Jul 25, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 20 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.0838 per EA (NDC 43598056601), effective Sep 30, 2026.
How has the price of FLUOXETINE HCL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 20 MG TABLET has declined 93.3%. It has been tracked across 428 weekly CMS publications since Jul 25, 2018.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 20 MG TABLET?
Since Jul 25, 2018, the NADAC for FLUOXETINE HCL 20 MG TABLET has ranged from a low of $0.0653 (Nov 20, 2024) to a high of $1.3043 (Sep 12, 2018), with a median of $0.2122 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 20 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUOXETINE HCL 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUOXETINE HCL 20 MG TABLET?
FLUOXETINE HCL 20 MG TABLET (NDC 43598056601) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.